ҽҩ֪ʶ
ҽҩ֪ʶ
ҽҩ֪ʶ
ҽҩѶ
  • ALK+/ROS1+СϸΰЧɫʹ˵

    LorlatinibALK+/ROS1+СϸΰORRΪ56.4%­ORRΪ74%36ALK+ΰ3ROS1ΰܹһ߻ƣLorlatinibʾ3ȫ⣬19ֻ߲⣬͹ۻORRΪ56.4%DCRΪ97.4%­ORRΪ74%­DCRΪ100%Ǹߵ̴Ѫ֢(82%3-425%)ˮ(71,8%)(38.5%)֤ʵLorlatinibALK+/ROS1+NSCLCнϸߵ­ڻԺõİȫԡᣨLorlatinibǵALK /

  • תȥƵֿǰٰmCPRCߵ

    911գThe Lancet Oncology߷һоʾ밢¬ȣתȥƵֿǰٰmCPRCߵCARDNCT02485691һġűǩٴо漰13ŷ޹ҹ62оġ18ꡢECOG PS2ֲȷΪmCPRCĻߣ22511󣬿黼Ϊ129¬黼Ϊ126ǰоʾ밢¬ȣƻߵ޽չڣPFSڣOSоҪ˻

  • תǰٰЧô

    Ӧ֢,ڽܹƷļתǰٰߵơŵ(Sanofi)˾з20106»FDA׼У20113»ŷEMA׼У20147»ձPMDA׼,ĿǰδҹСһһְϳɼ໯ǰɼҶȡãûɼҩơͨƻ˿ѺͼϸҪ΢òϸѺϸơҩ(prednisone)ƼԺϩɼ

  • 鵥ڹڻƸΰã

    ҩƷල֣NMPA׼PD-L1TecentriqatezolizumabϿѪƤӣVEGFAvastinδܹȫơгĸϸHCCߡIMbrave150оTecentriqAvastinʹÿŸƻߵԤ󡣸йΪйΰṩµѡ񣡡ΰйİ֢֮һÿϽ40Լ368,000൱ÿ쳬1000йΰߵƽ5ʽԼ15׼ǻIIIIMbrave150оĽ194й

  • ڷJAK1Ƽabrocitinib12жضӦƤ׻

    FDAabrocitinib100mg200mgҩ루NDA飬ҩһÿһΡڷJAK1Ƽ12жضӦƤףADߡabrocitinibһֿڷСӣѡԵJanusø1JAK1ӦƤףADһصġԤġͨʹ˥ƤԻ߼ճشӰ졣ڶٴУabrocitinibڻAD֢״кǿЧѸټabrocitinibļļǻһǿ3ٴĿĽ

  • NucalamepolizumabӦ֢Щ

    գŷҩƷ֣EMAҩNucalamepolizumabӪȨ루MAA3Ӧ֢ϸۺHESԱ-װϢ(CRSwNP)ϸѿԶѪףEGPAŷˣNucala׼ΪһָƷضϸSEAߡNucalaѱ׼3Ӧ֢SEAEPGAHESϸļSEAHESCRSwNPEGPAϸˮƽΪ֢Լ3MAAһϵйؼоĽЩ

  • ƷСϸΰô

    lorlatinibҩύǻһ/ٴڶ׶εݡڲͬнƵĻߵЧ54ALKROS1ԵNSCLCߣ߶ǾƻCNSתƵALK+/ROS1+NSCLCٴ275ALK+ROS1+NSCLCߣ߶תƲҶйALKҩǻƣ100mg qdƣORRԼԲORRڸݼƵͬΪEXP1δƣEXP2(֮ǰֻù)EXP33A֮ǰù+ƣ3B֮ǰù

  • ؽҩﰢ˹ʲôƣ˹ӡȰҩʲô

    ˹أApremilastOtezlaһ״ġڷѡø-4PDE-4Ƽ2014׺2015˹أApremilastOtezlaֱFDAŷ޼ܻ׼ڻмؽףPSAжضȰ߿мPlaque psoriasisơڶٴʾ˹أApremilastOtezla16ܣָסͷƤţ㣩мõƣ52ܾά֡ҩǹȥ20лмƵ׸ڷҩҲǹȥ15лмؽ׵׸ڷҩӡҩ

  • ȥͰ±ԭԵ֭ٻԸӲĸã

    PBCҪȥᣨ˼UDCAӦ𲻼ѺƲܵijֶƷսҩ±ᣨOCAΪPBCߴϣΪҩȥᡡûƣȥĿǰָƼPBCһҩҪûΪٽ֭ڣˮԵϸüյϸϸ͸ϸܶԵ֭ˣƵ֭ٻͼøALP-ȰתøGGT򵰰MIgMˮƽЧٴӦUDCAPBCף

  • ͡Ե͡ЩȺʹã

    ͡ЧΣһ3572򲡻ߵ˫äҩաƽ롢ЧԵIIIٴУ˷ֳ飺͡(100mgһһ)͡(25mgһһ)Ͱο顣24ܵҩʾǻѪ쵰Ũ(HBA1c)ͿոѪŨ͡Ͱ͡ʾЧԡһ1ڸղ򲡵ȺȺÿһβǰ͡100mg12ܣڷðο۲쵽ԵǻѪ쵰½ոѪǺͲͺСʱѪҲ

  • ڷҩ͡ôҩҪã

    2015꣬ձҩƳ͡2017꣬ϼ̿ҩƳ׿ư͡ҩȫеĵһһܷһεĿڷҩҩܹȺӭһܷһεȷdz㣬Ҳкܶ͡ĽҩһֻάѪŨȣȫ򲡡Ŀǰϻû򲡵ҩ͡Ľǻơ͡һֳЧĶĻø4DPP-4Ƽͼ£˽ͺСƤGLP-1̼ȵطڣͬʱȸѪطڣ

  • Trixeo Aerosphere(ظ)ԷβߵάƣйУ

    ŷҩƷ֣EMAҽҩƷίԱᣨCHMPշһݻƼ׼ʳƷҩ֣FDA׼Trixeo AerosphereƷ®®ε/¡/ḣĪޣظԷβCOPDߵάơTrixeo AerosphereһƷձй׼ƷBreztri AerosphereۣCOPDߵάơCHMPĻIIIETHOSԽʾжضԷβCOPD

  • άпvenclextaһƼ԰ѪЧΣڹ

    գFDA׼ҩVenclextavenetoclaxάпˣϰգAZAͼǰգLDACϵļ԰ѪAML˻ߡ԰ѪAMLϮԺƵѪҺ֢֮һʺܵͣƷҲdzޡAMLڹγɣѪҺ͹쳣ϸӡAMLͨܿ񻯣л߶ʸǿơͺϲ֢ǿƵijءֻдԼ28%Ļܹ5ʱ䡣VenclextaĻҩɷΪvenetoclaxһֿڷBϸ

  • ΰحϣΰЧΣ

    գFDA򿹰ҩϣһݲҩ루sNDA顣Ѱ׼ȫгڣIB/II/IIIAڣƤͻ䣨EGFRmСϸΰNSCLCߣơϣһֿڷСӵƤҰἤøƼEGFR-TKIѱȫңձйŷˣ׼1һƾֲڻתEGFRm NSCLCߣ2EGFR T790MͻԵľֲڻתNSCLCߡIIIADAURAоʷǰ

  • ŷ֣Чᣡ

    ϸdz͡RCCеķʴԼŮԵ2ȫΧڣΪתԻĻߣ5ʽΪ12.1%գFDAѷֱһݲƷ루sBLAͲҩ루sNDAPD-1ƷOpdivoŷ֣ͨnivolumabȵϰ򿹰ҩϸRCCߡЩڹؼIIICheckMate-9ERĽCheckMate-9ERо֤OpdivoCabometyx+ƷһڻתRCCߣ޽չ

  • TremfyaŵšⵥмؽЧΣTremfyaйضȰ߿״м

    գŷҩƷ֣EMAҽҩƷίԱᣨCHMP׼Tremfyaŵ®ͨguselkumabⵥʺϵͳƷĻмؽףPsA˻ߡŷˣTremfya201711״λʺϵͳƷжضȰ߿м˻ߡPsAһԹؽʹƤ֢ΪԽԼٴоʾ밲οȣTremfya˻PsAߵĹؽڡƤ֢֯״׼TremfyaΪŷ׸ͬʱPsAضȰ߿мѡ

  • о˥߻ŷ˻ой2򲡻߸Ѫǿƣ

    оһ״ġÿտڷһεġѡ-Эͬת˵ףSGLT2ƼȵطãѡSGLT2ɰߴҺųǡ˽֮⣬ҩмʺͽѪѹĶ洦йdapagliflozinƷƣ20173»ΪһֵҩƷ2򲡳˻߸Ѫǿơ˴׼ʹdapagliflozinΪйг׼׸SGLT2ƼҩһֿڷƬÿƬ5mg10mgоƼʼΪÿ5mgÿϷ1Ρҩ׼

  • ȺöܷЧϼֱ

    һִѪС弤ѪС֢Ƥʼء򵰰׻ƢгӦѵĻߡҩѪСͳѪաĿǰҪΪITPĶơҪðе㶼ھ޺ϸѪǰϸֻDz޺ϸĵ͵ITPЧܿЧһ㰬2-4ܲЧӰITPЧ˵ҩһЧǰٷְЧҪäĿáҲȫ㻼Ҫס

  • Dupixent׼Ӧ֢6-11ͯӦƤ׻ߣйУ

    ӦƤһԡԡ֢ƤԷľƤΪҪٴ֣߳ϲԱסӦԼŷҩƷ֣EMAҽҩƷίԱᣨCHMPѷһݻ׼DupixentƷףͨdupilumabȵȺʺϵͳƷ6-11жضӦƤףADͯߡ6£DupixentFDA׼ȺͬΣ6-11꣩ضADͯߡDupixentǵһҲΨһһ

  • TremfyaŵЧͰȫΣڹУ

    мһԡԡ֢ԡϵͳԼѣйм߶ΪѰͣмӰ컼мֺϲ֢ʹûߡTremfyaŵ/ⵥǵһ׽23IL-23ֱӣ׽-23Ϊ߿м֢״ؼ֮һ߿״мȷԭвоȻԾϵͳʹƤϸѻƤ棬γɰ߿顣20181126գTREMFYAŵţۻУжȼضȵİ߿м껼ߡ2019

共有82页首页上一页123456789下一页尾页
客服中心
联系方式
400-001-9763
- ѯ
ɨάѯ